Literature DB >> 20156807

A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells.

Katharina Hansen1, Franz-Josef Müller, Markus Messing, Frank Zeigler, Jeanne F Loring, Katrin Lamszus, Manfred Westphal, Nils Ole Schmidt.   

Abstract

Neural stem/progenitor cells (NSPCs) display inherent pathotropic properties that can be exploited for targeted delivery of therapeutic genes to invasive malignancies in the central nervous system. Optimizing transplantation efficiency will be essential for developing relevant NSPC-based brain tumor therapies. To date, the real-world issue of handling and affixing NSPCs in the context of the neurosurgical resection cavity has not been addressed. Stem cell transplantation using biocompatible devices is a promising approach to counteract poor NSPC graft survival and integration in various types of neurological disorders. Here, we report the development of a 3-dimensional substrate that is based on extracellular matrix purified from tissue-engineered skin cultures (3DECM). 3DECM enables the expansion of embedded NSPCs in vitro while retaining their uncommitted differentiation status. When implanted in intracerebral glioma models, NSPCs were able to migrate out of the 3DECM to targeted glioma growing in the contralateral hemisphere, and this was more efficient than the delivery of NSPC by intracerebral injection of cell suspensions. Direct application of a 3DECM implant into a tumor resection cavity led to a marked NSPC infiltration of recurrent glioma. The semisolid consistency of the 3DECM implants allowed simple handling during the surgical procedure of intracerebral and intracavitary application and ensured continuous contact with the surrounding brain parenchyma. Here, we demonstrate proof-of-concept of a matrix-supported transplantation of tumor-targeting NSPC. The semisolid 3DECM as a delivery system for NSPC has the potential to increase transplantation efficiency by reducing metabolic stress and providing mechanical support, especially when administered to the surgical resection cavity after brain tumor removal.

Entities:  

Mesh:

Year:  2010        PMID: 20156807      PMCID: PMC2940655          DOI: 10.1093/neuonc/noq002

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  39 in total

Review 1.  Collagen fillers.

Authors:  Leslie Baumann; Joely Kaufman; Sogol Saghari
Journal:  Dermatol Ther       Date:  2006 May-Jun       Impact factor: 2.851

Review 2.  Getting the right stuff: controlling neural stem cell state and fate in vivo and in vitro with biomaterials.

Authors:  Ana I Teixeira; Joshua K Duckworth; Ola Hermanson
Journal:  Cell Res       Date:  2007-01       Impact factor: 25.617

3.  Injectable collagens: lost but not forgotten--a review of products, indications, and injection techniques.

Authors:  Seth L Matarasso
Journal:  Plast Reconstr Surg       Date:  2007-11       Impact factor: 4.730

4.  Establishment of three-dimensional culture of neural stem/progenitor cells in collagen Type-1 Gel.

Authors:  Kota Watanabe; Masaya Nakamura; Hideyuki Okano; Yoshiaki Toyama
Journal:  Restor Neurol Neurosci       Date:  2007       Impact factor: 2.406

5.  Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.

Authors:  Seung-Ki Kim; Seung U Kim; In Ho Park; Jung Hee Bang; Karen S Aboody; Kyu-Chang Wang; Byung-Kyu Cho; Manho Kim; Lata G Menon; Peter M Black; Rona S Carroll
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

6.  Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.

Authors:  Walter Stummer; Hanns-Jürgen Reulen; Thomas Meinel; Uwe Pichlmeier; Wiebke Schumacher; Jörg-Christian Tonn; Veit Rohde; Falk Oppel; Bernd Turowski; Christian Woiciechowsky; Kea Franz; Torsten Pietsch
Journal:  Neurosurgery       Date:  2008-03       Impact factor: 4.654

Review 7.  Stem and progenitor cell-mediated tumor selective gene therapy.

Authors:  K S Aboody; J Najbauer; M K Danks
Journal:  Gene Ther       Date:  2008-03-27       Impact factor: 5.250

Review 8.  CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure.

Authors:  Michael T Fitch; Jerry Silver
Journal:  Exp Neurol       Date:  2007-05-31       Impact factor: 5.330

9.  Targeting of melanoma brain metastases using engineered neural stem/progenitor cells.

Authors:  Karen S Aboody; Joseph Najbauer; Nils Ole Schmidt; Wendy Yang; Julian K Wu; Yuzheng Zhuge; Wojciech Przylecki; Rona Carroll; Peter M Black; George Perides
Journal:  Neuro Oncol       Date:  2006-03-08       Impact factor: 12.300

10.  Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.

Authors:  Justin S Smith; Edward F Chang; Kathleen R Lamborn; Susan M Chang; Michael D Prados; Soonmee Cha; Tarik Tihan; Scott Vandenberg; Michael W McDermott; Mitchel S Berger
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

View more
  9 in total

1.  Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.

Authors:  Kevin T Sheets; Matthew G Ewend; Mahsa Mohiti-Asli; Stephen A Tuin; Elizabeth G Loboa; Karen S Aboody; Shawn D Hingtgen
Journal:  Mol Ther       Date:  2020-02-13       Impact factor: 11.454

2.  Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.

Authors:  Jordi Martinez-Quintanilla; Derek He; Hiroaki Wakimoto; Ramon Alemany; Khalid Shah
Journal:  Mol Ther       Date:  2014-10-29       Impact factor: 11.454

3.  Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution.

Authors:  Rachael Mooney; Yiming Weng; Revathiswari Tirughana-Sambandan; Valerie Valenzuela; Soraya Aramburo; Elizabeth Garcia; Zhongqi Li; Margarita Gutova; Alexander J Annala; Jacob M Berlin; Karen S Aboody
Journal:  Future Oncol       Date:  2014-02       Impact factor: 3.404

4.  Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma.

Authors:  Matthias Reitz; Maria Demestre; Jan Sedlacik; Hildegard Meissner; Jens Fiehler; Seung U Kim; Manfred Westphal; Nils Ole Schmidt
Journal:  Stem Cells Transl Med       Date:  2012-11-27       Impact factor: 6.940

Review 5.  Stem cell-based therapies for cancer treatment: separating hope from hype.

Authors:  Daniel W Stuckey; Khalid Shah
Journal:  Nat Rev Cancer       Date:  2014-09-01       Impact factor: 60.716

6.  Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells.

Authors:  Juliane Klose; Nils Ole Schmidt; Arthur Melms; Makoto Dohi; Jun-ichi Miyazaki; Felix Bischof; Bernhard Greve
Journal:  J Neuroinflammation       Date:  2013-09-22       Impact factor: 8.322

7.  Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model.

Authors:  Michael E Barish; Kelsey Herrmann; Yang Tang; Siranush Argalian Herculian; Marianne Metz; Soraya Aramburo; Revathiswari Tirughana; Margarita Gutova; Alexander Annala; Rex A Moats; Leanne Goldstein; Russell C Rockne; Jennifer Gutierrez; Christine E Brown; Lucy Ghoda; Karen S Aboody
Journal:  Stem Cells Transl Med       Date:  2017-05-08       Impact factor: 6.940

Review 8.  Stem cells in cancer therapy: opportunities and challenges.

Authors:  Cheng-Liang Zhang; Ting Huang; Bi-Li Wu; Wen-Xi He; Dong Liu
Journal:  Oncotarget       Date:  2017-09-08

9.  Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma.

Authors:  Lasse Dührsen; Sophie Hartfuß; Daniela Hirsch; Sabine Geiger; Cecile L Maire; Jan Sedlacik; Christine Guenther; Manfred Westphal; Katrin Lamszus; Felix G Hermann; Nils Ole Schmidt
Journal:  Oncotarget       Date:  2019-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.